{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:17:50Z","timestamp":1791980270680,"version":"4.4.0"},"reference-count":17,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,2,13]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>PD-L1 is variably expressed in MCs from patients with SM and CM. PD-1 is expressed in MCs in a subset of patients with CM, but not SM.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017011551","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T20:45:19Z","timestamp":1517258719000},"page":"189-199","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["Variability of PD-L1 expression in mastocytosis"],"prefix":"10.1182","volume":"2","author":[{"given":"Ellen W.","family":"Hatch","sequence":"first","affiliation":[{"name":"Department of Pathology, University of New Mexico, Albuquerque, NM;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Geeze","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of New Mexico, Albuquerque, NM;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheyenne","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of New Mexico, Albuquerque, NM;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6696-0061","authenticated-orcid":false,"given":"Mohamed E.","family":"Salama","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4595-8226","authenticated-orcid":false,"given":"Karin","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Luebeck, Luebeck, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Eisenwort","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hemostaseology, Department of Internal Medicine I, and"},{"name":"Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Blatt","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hemostaseology, Department of Internal Medicine I, and"},{"name":"Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-5095","authenticated-orcid":false,"given":"Peter","family":"Valent","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hemostaseology, Department of Internal Medicine I, and"},{"name":"Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Gotlib","sequence":"additional","affiliation":[{"name":"Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8502-3679","authenticated-orcid":false,"given":"Heather H.","family":"Ward","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center and"},{"name":"Department of Internal Medicine, University of New Mexico, Albuquerque, NM"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8533-6029","authenticated-orcid":false,"given":"Diane S.","family":"Lidke","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of New Mexico, Albuquerque, NM;"},{"name":"Comprehensive Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-7847","authenticated-orcid":false,"given":"Tracy I.","family":"George","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of New Mexico, Albuquerque, NM;"},{"name":"Comprehensive Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"2019111616105491900_B1","first-page":"911","article-title":"Mastocytosis","author":"George","year":"2017","edition":"2nd ed"},{"issue":"7","key":"2019111616105491900_B2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"issue":"23","key":"2019111616105491900_B3","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019111616105491900_B4","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3324\/haematol.2016.146563","article-title":"Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice","volume":"101","author":"Ustun","year":"2016","journal-title":"Haematologica"},{"issue":"8","key":"2019111616105491900_B5","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.4049\/jimmunol.1401572","article-title":"The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity","volume":"193","author":"Ostrand-Rosenberg","year":"2014","journal-title":"J Immunol"},{"issue":"2","key":"2019111616105491900_B6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.coi.2011.12.009","article-title":"Targeting the PD-1\/B7-H1(PD-L1) pathway to activate anti-tumor immunity","volume":"24","author":"Topalian","year":"2012","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"2019111616105491900_B7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jaci.2015.07.006","article-title":"Expression of programmed cell death ligand-1 in mastocytosis correlates with disease severity","volume":"137","author":"Rabenhorst","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"2019111616105491900_B8","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/annonc\/mdu047","article-title":"Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal","volume":"25","author":"Valent","year":"2014","journal-title":"Ann Oncol"},{"issue":"11","key":"2019111616105491900_B9","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"issue":"2 Pt A","key":"2019111616105491900_B10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.molimm.2015.02.009","article-title":"Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy","volume":"67","author":"Swaika","year":"2015","journal-title":"Mol Immunol"},{"issue":"5","key":"2019111616105491900_B11","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaad.2015.09.029","article-title":"Expression of PD-L1 in mastocytosis","volume":"74","author":"Kuklinski","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"127","key":"2019111616105491900_B12","doi-asserted-by":"crossref","first-page":"127ra37","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci Transl Med"},{"issue":"13","key":"2019111616105491900_B13","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1084\/jem.20161462","article-title":"What does PD-L1 positive or negative mean?","volume":"213","author":"Ribas","year":"2016","journal-title":"J Exp Med"},{"issue":"4","key":"2019111616105491900_B14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"7528","key":"2019111616105491900_B15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"issue":"10","key":"2019111616105491900_B16","doi-asserted-by":"crossref","first-page":"e1029704","DOI":"10.1080\/2162402X.2015.1029704","article-title":"Innate vs. adaptive: PD-L1-mediated immune resistance by melanoma","volume":"4","author":"Berry","year":"2015","journal-title":"OncoImmunology"},{"issue":"1","key":"2019111616105491900_B17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2332\/allergolint.12-OA-0450","article-title":"PD-1 regulates the growth of human mastocytosis cells","volume":"62","author":"Kataoka","year":"2013","journal-title":"Allergol Int"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/3\/189\/880165\/advances011551.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/3\/189\/880165\/advances011551.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T16:11:05Z","timestamp":1573920665000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/3\/189\/15778\/Variability-of-PDL1-expression-in-mastocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,29]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,2,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017011551","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732713970.793566959","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,29]]}}}